NCT00752531.
Methods |
Study design: single‐blinded, parallel individual randomised controlled trial Duration: 78 weeks Setting: unknown |
Participants |
Population: 280 adult participants to be recruited in the United States Baseline characteristics: unknown Inclusion criteria: ≥ 21 years, understands English, has working telephone/cable, with diagnosed COPD, stage II/III COPD Exclusion criteria: moving from study area before study complete, health condition causing participant to not carry out study expectations, not able to use telephone and without assistance to do so |
Interventions | Measurements at baseline and at 3, 6, 9, 12, 15, and 18 months Treatment arms
|
Outcomes |
Primary outcomes: lung function, respiratory symptoms Secondary outcomes: quality of life, use of health care, activities of daily living, self‐efficacy, exercise tolerance |
Notes |
Funding: John Hopkins University Other identifier:NCT00752531 |